Open AccessSurvival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study
Author(s) -
Abdalla Aly,
Prianka Singh,
Beata Korytowsky,
You-Li Ling,
Hrishikesh Kale,
Homa Dastani,
Marc Botteman,
Andrew D. Norden
Publication year - 2019
Publication title -
neuro-oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 14
eISSN - 2054-2585
pISSN - 2054-2577
DOI - 10.1093/nop/npz042
Subject(s) - observational study , glioblastoma , retrospective cohort study , medicine , health care , line (geometry) , resource use , family medicine , political science , economics , geometry , mathematics , cancer research , natural resource economics , law
Glioblastoma (GBM) is associated with poor prognosis, large morbidity burden, and limited treatment options. This analysis evaluated real-world treatment patterns, overall survival, resource use, and costs among Medicare patients with GBM.